You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug

Published Date: 25 Sep 2025

Revision Summary:
Drug Monograph: New drug monograph
Patient Info Sheet EN: New drug information sheet
Sep 2025
Drug

Published Date: 24 Sep 2025

Revision Summary:
Drug Monograph: Updated fluorouracil antidote information in the Administration Guidelines section
Sep 2025
Regimen
Published Date: 22 Sep 2025
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Drug Regimen, Adverse Effects, Interactions, Administration, Pregnancy/Lactation, and Monitoring sections

Sep 2025
Regimen
Published Date: 22 Sep 2025
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Drug Regimen, Adverse Effects, Interactions, Administration, Pregnancy/Lactation, and Monitoring sections

Sep 2025
Regimen
Published Date: 22 Sep 2025
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Drug Regimen, Adverse Effects, Interactions, Administration, Pregnancy/Lactation, and Monitoring sections

Sep 2025
Regimen
Published Date: 22 Sep 2025
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Drug Regimen, Adverse Effects, Interactions, Administration, Pregnancy/Lactation, and Monitoring sections

Sep 2025
Regimen
Published Date: 19 Sep 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Drug Regimen section

Sep 2025
Regimen
Published Date: 19 Sep 2025
Cancer Type:
Gastrointestinal, 
Colorectal
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Rationale/Uses section

Sep 2025
Regimen
Published Date: 19 Sep 2025
Cancer Type:
Gastrointestinal, 
Colorectal
Intent: Palliative
Revision Summary:
Regimen Monograph: Modified Rationale/Uses section
Sep 2025
Regimen
Published Date: 18 Sep 2025
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Sep 2025
Regimen
Published Date: 18 Sep 2025
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Intent: Neoadjuvant, Curative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Sep 2025
Regimen
Published Date: 18 Sep 2025
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Sep 2025

Pages